# Hydroxyl Free Radical Associated Effects of SGLT-2 Inhibitors in Type 2 Diabetes

> **NCT06797115** · — · COMPLETED · sponsor: **University of Pecs** · enrollment: 40 (actual)

## Conditions studied

- T2DM

## Interventions

- **DRUG:** SGLT-2 inhibitor

## Key facts

- **NCT ID:** NCT06797115
- **Lead sponsor:** University of Pecs
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-18
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06797115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06797115, "Hydroxyl Free Radical Associated Effects of SGLT-2 Inhibitors in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06797115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*